August 2023: Horizon Ranked No. 1 in Survey of Rare Disease Patient Advocacy Groups, Plus Our Patient-Centric Approach to Research and Development

August 2023: Horizon Ranked No. 1 in Survey of Rare Disease Patient Advocacy Groups, Plus Our Patient-Centric Approach to Research and Development

Take a look at the top five things that happened at Horizon this month.

1.?Horizon Reports Second-Quarter 2023 Financial Results

We announced our second quarter 2023 financial results on Aug. 8. Learn more: https://t.co/SLPt757vEN.


2.?Rare Disease Patient Advocacy Groups Rank Horizon No. 1 in Corporate Reputation, Much More

A total of 91 rare disease patient advocacy groups familiar with Horizon ranked the company No. 1 in overall corporate reputation in rare disease with their responses to PatientView’s 2022 global “Corporate Reputation of Pharma” survey, which evaluated 34 different pharma and biotech companies. In addition, 59 rare disease patient advocacy groups who said they had worked with Horizon placed the company at No. 1 in 10 of 14 survey areas, including patient-centricity, patient information, integrity, access to medicines, relationships and services “beyond the pill.” Learn more: https://t.co/zsfAqODez2.


3.?Liz Thompson Shares Horizon’s Patient-Centric Approach With WSJ

In an article published in The Wall Street Journal, Liz Thompson, executive vice president, research and development, shares why listening to patients living with rare diseases and incorporating their experience leads to better and potentially more effective therapies throughout the medicine development life cycle. Read more: https://bit.ly/3DPetrS.


4.?‘Through the Lens of a Scientist’ With Biostatistician Sun Kim

For Sun Kim, senior director, biostatistics, becoming an accomplished biostatistician who helps to deliver transformational medicines to patients wasn’t a career path she originally envisioned. In a new Horizon Stories blog post, learn what inspired her to come to Horizon and how she’s now paying it forward: https://bit.ly/3EeNVkh.


5. Horizon Scholars Visit U.S. Headquarters in Deerfield, Ill.

We were thrilled to host several Horizon Scholars at our U.S. headquarters in Deerfield, Ill. where they learned more about interviewing, internships and career paths through a series of sessions with Horizon employees. Read more about our Horizon Scholars program assisting future STEM leaders in this Block Club Chicago piece: https://bit.ly/44TcuyH.

La Toija Snodgrass

Senior Patient Advocacy & Health Equity Leader| Strategist| and Consultant

1 年

Remarkable!

回复
Desiree Wienand

National Director @ Lupus Foundation | Patient Advocacy, Corporate Philanthropy

1 年

You are an incredible company that puts patient advocacy at the core of everything you do. Well-deserved!

Mike Smith

Biotech/Biopharma Executive

1 年

congrats Tim

回复
Luisa Leal

Founder & CEO at The Akari Foundation. for kids with DMD, BECKER, LMGD, SMA and other rare diseases | Disabilities & DEI advocate | Key Note speaker.

1 年

You guys are the best, and I love to work with y'all, Thank you for believing In us and supporting our Mission.

要查看或添加评论,请登录

社区洞察

其他会员也浏览了